N = 285 | % | |
---|---|---|
Gender | ||
Male | 141 | 50.5 |
Female | 144 | 49.5 |
Age at surgery(Median) | 25(17–37) | |
BMI(kg/m2) (Median) | 22.6(19–27) | |
Disease duration (months) | 48(23.7–120) | |
Smoking | ||
Never | 222 | 77.9 |
Prior | 56 | 19.6 |
Current | 7 | 2.5 |
Disease extent | ||
E2 Left-side colitis | 35 | 12.3 |
E3 Pancolitis | 250 | 87.7 |
Disease Severity | ||
S2 Moderate UC | 199 | 69.8 |
S3 Severe UC | 86 | 30.2 |
Disease activity | ||
Acute | 18 | 93.7 |
chronic | 267 | 6.3 |
Medication history | ||
Steroid | 90 | 31.6 |
6-MP or MTX | 196 | 68.8 |
Immunosuppressant | ||
Non-biologics | 77 | 27 |
Anti-TNF | 183 | 64.2 |
Anti-TNF adding Vedolizumab | 25 | 8.8 |
Operation type | ||
Laparoscopy | 209 | 73.3 |
Open | 76 | 26.7 |
Operation performed | ||
Total abdominal colectomy +end stoma | 92 | 32.3 |
Protectomy + IPAA with ileostomy | 193 | 67.7 |
Preoperative labs | ||
Leukocyte(× 103/uL) (Median) | 9.4(6.6–12.5) | |
Platelet(×103/uL) (Median) | 350(274–475) | |
Albumin(g/dl) (Median) | 3.7(3.3–4.0) |